10/8/2025Only Two Novel Drugs Win China Approval in September as Local Innovati...

10/8/2025License-Out Deals in China Drop Sharply in September Amid Steady Deal ...

10/8/2025China Biopharma Financing Rebounds in September as IPO Pipeline Surges

10/3/2025GRIT Biotech Raises CNY 380M in Series C Round

10/3/2025TJ Biopharma Secures CNY 600M to Advance Late-Stage Cancer and Rare D...

10/3/2025Santen and RemeGen Files Chinese BLA for RC28-E

10/3/2025OncoC4 Raises $50M in Series B to Advance Next-Generation Cancer Thera...

10/3/2025​​​​​​​BeOne and AbbVie Resolve Patent Dispute Over BTK Inhibit...

10/3/2025Medilink Initiates U.S. Phase 1/2 Trial for VEGF-Targeted ADC YL242

10/3/2025Baidu-Backed Biotech Start-up Aims to Overtake AlphaFold in China's AI...

10/1/2025Full-Life Tech Nets $77M to Propel Radiopharma Ambitions

More>>

9/23/2025Challenges and Opportunities in Oncology Drug Development and Clinical...

9/23/2025China's Edge over U.S. Biotech Was Never Scientific (Washington Post)

9/22/2025China's Role in Global Drug Approvals Expands as Regulatory Timelines ...

9/19/2025PRC Consolidates Pharmaceutical Supply Chain Dominance (TJF)

9/19/2025​​​​​​​China Biopharma at Crossroads: A Mid-2025 Tale of Contra...

9/19/2025Gottlieb Cautions Blanket China Drug Licensing Ban amid Calls for Rigo...

9/19/2025Obesity in China (The Lancet)

9/19/2025China's Biotechs Navigate the Demands of International Trials (Clinica...

9/18/2025On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (C...

9/18/2025Strengthening Oversight of Imported Drugs: Key Takeaways into New Regu...

9/15/2025Merger Control in China's Healthcare Industry: Insights into Antitrust...

More>>